384 related articles for article (PubMed ID: 16381022)
21. Gallstones and the risk of biliary tract cancer: a population-based study in China.
Hsing AW; Gao YT; Han TQ; Rashid A; Sakoda LC; Wang BS; Shen MC; Zhang BH; Niwa S; Chen J; Fraumeni JF
Br J Cancer; 2007 Dec; 97(11):1577-82. PubMed ID: 18000509
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China.
Castro FA; Koshiol J; Hsing AW; Gao YT; Rashid A; Chu LW; Shen MC; Wang BS; Han TQ; Zhang BH; Niwa S; Yu K; Zhang H; Chanock S; Andreotti G
BMC Cancer; 2012 Oct; 12():468. PubMed ID: 23057767
[TBL] [Abstract][Full Text] [Related]
23. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
Ye Z; Parry JM
Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
[TBL] [Abstract][Full Text] [Related]
24. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
[TBL] [Abstract][Full Text] [Related]
26. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
Haiman CA; Stampfer MJ; Giovannucci E; Ma J; Decalo NE; Kantoff PW; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):743-8. PubMed ID: 11440959
[TBL] [Abstract][Full Text] [Related]
27. Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China.
Andreotti G; Hou L; Gao YT; Brinton LA; Rashid A; Chen J; Shen MC; Wang BS; Han TQ; Zhang BH; Sakoda LC; Fraumeni JF; Hsing AW
Br J Cancer; 2010 Mar; 102(7):1185-9. PubMed ID: 20216539
[TBL] [Abstract][Full Text] [Related]
28. Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation.
Andreotti G; Liu E; Gao YT; Safaeian M; Rashid A; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Hsing AW
Cancer Causes Control; 2011 Sep; 22(9):1289-96. PubMed ID: 21744094
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.
Song G; Gu L; Tian F; Bao Q; Tang Z; Wang S
Medicina (Kaunas); 2013; 49(2):51-5. PubMed ID: 23888338
[TBL] [Abstract][Full Text] [Related]
30. Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China.
Zhang XH; Andreotti G; Gao YT; Deng J; Liu E; Rashid A; Wu K; Sun L; Sakoda LC; Cheng JR; Shen MC; Wang BS; Han TQ; Zhang BH; Gridley G; Fraumeni JF; Hsing AW
Int J Cancer; 2006 Jun; 118(12):3089-94. PubMed ID: 16395699
[TBL] [Abstract][Full Text] [Related]
31. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
Haiman CA; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1999 Mar; 59(5):1015-20. PubMed ID: 10070957
[TBL] [Abstract][Full Text] [Related]
32. Diet and biliary tract cancer risk in Shanghai, China.
Nelson SM; Gao YT; Nogueira LM; Shen MC; Wang B; Rashid A; Hsing AW; Koshiol J
PLoS One; 2017; 12(3):e0173935. PubMed ID: 28288186
[TBL] [Abstract][Full Text] [Related]
33. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.
Sata F; Yamada H; Yamada A; Kato EH; Kataoka S; Saijo Y; Kondo T; Tamaki J; Minakami H; Kishi R
Mol Hum Reprod; 2003 Nov; 9(11):725-8. PubMed ID: 14561815
[TBL] [Abstract][Full Text] [Related]
34. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
Goodman MT; Yamamoto J
Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.
Mao C; Wang XW; He BF; Qiu LX; Liao RY; Luo RC; Chen Q
Breast Cancer Res Treat; 2010 Jul; 122(1):259-65. PubMed ID: 20033766
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study.
Ahrens W; Timmer A; Vyberg M; Fletcher T; Guénel P; Merler E; Merletti F; Morales M; Olsson H; Olsen J; Hardell L; Kaerlev L; Raverdy N; Lynge E
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):623-30. PubMed ID: 17625430
[TBL] [Abstract][Full Text] [Related]
37. Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China.
Shebl FM; Andreotti G; Rashid A; Gao YT; Yu K; Shen MC; Wang BS; Li Q; Han TQ; Zhang BH; Fraumeni JF; Hsing AW
Br J Cancer; 2010 Jun; 103(1):115-9. PubMed ID: 20517308
[TBL] [Abstract][Full Text] [Related]
38. Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
Renard P; Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
J Epidemiol Community Health; 1987 Dec; 41(4):344-8. PubMed ID: 3455429
[TBL] [Abstract][Full Text] [Related]
39. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China.
Hsing AW; Sakoda LC; Rashid A; Andreotti G; Chen J; Wang BS; Shen MC; Chen BE; Rosenberg PS; Zhang M; Niwa S; Chu L; Welch R; Yeager M; Fraumeni JF; Gao YT; Chanock SJ
Cancer Res; 2008 Aug; 68(15):6442-52. PubMed ID: 18676870
[TBL] [Abstract][Full Text] [Related]
40. [A survey on the diagnosis and treatment of biliary tract cancers in Shanghai].
Wang BS; Qin J; Deng J; Zhang BH; Han TQ; Shen MC; Rashid A; Hsing AW; Gao YT
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):455-9. PubMed ID: 15854373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
